Prevalencia de uso de drogas ilícitas y medicamentos psicotrópicos en México, Ensanut Continua 2023.

Saved in:

Bibliographic Details
Title:	Prevalencia de uso de drogas ilícitas y medicamentos psicotrópicos en México, Ensanut Continua 2023.
Authors:	Sánchez-Pájaro, Andrés¹, Barrera-Núñez, David A.¹, Carnalla, Martha¹, Mendoza-Alvarado, Laura Rosario², Robles-Soto, Nadia, Ledesma-Torres, Lucía³, López-Olmedo, Nancy¹, Fleiz-Bautista, Clara⁴, Reynales-Shigematsu, Luz Myriam¹, Lazcano-Ponce, Eduardo⁵, Barrientos-Gutiérrez, Tonatiuh¹ tbarrientos@insp.mx
Source:	Salud Pública de México. nov/dec2025, Vol. 67 Issue 6, p777-784. 8p.
Subjects:	DRUG abuse, PSYCHIATRIC drugs, TEENAGERS, DISEASE prevalence, COUNTRIES, HUMAN settlements
Geographic Terms:	MEXICO
Abstract (English):	Objective. To estimate the prevalence of illicit drug use and non-medical use of psychotropic medications among the Mexican population in 2023. Materials and methods. We used data from the 2023 Encuesta Nacional de Salud y Nutrición Continua. We constructed indicators for lifetime and past-year use. Prevalence estimates were calculated with 95% confidence intervals. Stratification was performed by age group, sex, and locality size. Results. The lifetime prevalence of illicit drug use was 14.1%. The most commonly used illicit drug was marijuana. The prevalence of non-medical use of psychotropic medications was 1.5%. Prevalence was higher among men and in urban areas. Conclusions. One in seven individuals has used an illicit drug at some point in their life. Past-year use has remained stable. The findings suggest an increase in experimental use, particularly among adolescents, young adults, and women. [ABSTRACT FROM AUTHOR]
Abstract (Spanish):	Objetivo. Estimar la prevalencia de uso de drogas ilícitas y medicamentos psicotrópicos sin indicación médica en población mexicana en 2023. Material y métodos. Se utilizó la Encuesta Nacional de Salud y Nutrición Continua 2023. Se construyeron indicadores de uso alguna vez en la vida y en el último año. Se estimó la prevalencia con intervalos de confianza al 95%. Se estratificó por grupo de edad, sexo y tamaño de la localidad. Resultados. La prevalencia de uso de drogas ilícitas alguna vez en la vida fue 14.1%. La droga ilícita más usada fue mariguana. La prevalencia de uso de medicamentos psicotrópicos sin indicación médica fue de 1.5%. Las prevalencias fueron más altas en hombres y en localidades urbanas. Conclusiones. Una de cada siete personas usó una droga ilícita alguna vez en su vida. El uso en el último año se ha mantenido constante. Los hallazgos sugieren un aumento del uso experimental, particularmente entre adolescentes, jóvenes y mujeres. [ABSTRACT FROM AUTHOR]
	Copyright of Salud Pública de México is the property of Instituto Nacional de Salud Publica and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database:	MedicLatina

Description
Abstract:	Objective. To estimate the prevalence of illicit drug use and non-medical use of psychotropic medications among the Mexican population in 2023. Materials and methods. We used data from the 2023 Encuesta Nacional de Salud y Nutrición Continua. We constructed indicators for lifetime and past-year use. Prevalence estimates were calculated with 95% confidence intervals. Stratification was performed by age group, sex, and locality size. Results. The lifetime prevalence of illicit drug use was 14.1%. The most commonly used illicit drug was marijuana. The prevalence of non-medical use of psychotropic medications was 1.5%. Prevalence was higher among men and in urban areas. Conclusions. One in seven individuals has used an illicit drug at some point in their life. Past-year use has remained stable. The findings suggest an increase in experimental use, particularly among adolescents, young adults, and women. [ABSTRACT FROM AUTHOR]
ISSN:	00363634
DOI:	10.21149/16856